Avantor, Inc. (NYSE:AVTR) Shares Purchased by New York State Teachers Retirement System

New York State Teachers Retirement System increased its holdings in shares of Avantor, Inc. (NYSE:AVTR) by 3.0% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 337,351 shares of the company’s stock after purchasing an additional 9,813 shares during the quarter. New York State Teachers Retirement System’s holdings in Avantor were worth $7,108,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. MassMutual Private Wealth & Trust FSB boosted its holdings in Avantor by 99.5% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,253 shares of the company’s stock worth $26,000 after acquiring an additional 625 shares during the period. Nisa Investment Advisors LLC boosted its holdings in Avantor by 69.6% in the 3rd quarter. Nisa Investment Advisors LLC now owns 2,035 shares of the company’s stock worth $53,000 after acquiring an additional 835 shares during the period. UMB Bank n.a. boosted its holdings in Avantor by 56.3% in the 4th quarter. UMB Bank n.a. now owns 2,981 shares of the company’s stock worth $63,000 after acquiring an additional 1,074 shares during the period. CKW Financial Group boosted its holdings in Avantor by 116.7% in the 4th quarter. CKW Financial Group now owns 5,200 shares of the company’s stock worth $110,000 after acquiring an additional 2,800 shares during the period. Finally, First Horizon Advisors Inc. boosted its holdings in Avantor by 30.8% in the 3rd quarter. First Horizon Advisors Inc. now owns 5,629 shares of the company’s stock worth $146,000 after acquiring an additional 1,326 shares during the period. Institutional investors and hedge funds own 95.08% of the company’s stock.

Avantor Trading Up 2.2 %

NYSE:AVTR opened at $17.73 on Thursday. The company has a quick ratio of 0.70, a current ratio of 1.07 and a debt-to-equity ratio of 0.54. Avantor, Inc. has a 1-year low of $17.14 and a 1-year high of $28.00. The firm has a market capitalization of $12.07 billion, a price-to-earnings ratio of 17.05, a price-to-earnings-growth ratio of 1.60 and a beta of 1.28. The stock has a fifty day simple moving average of $21.16 and a 200 day simple moving average of $23.05.

Avantor (NYSE:AVTR) last announced its quarterly earnings data on Wednesday, February 12th. The company reported $0.27 EPS for the quarter, topping analysts’ consensus estimates of $0.26 by $0.01. Avantor had a return on equity of 12.17% and a net margin of 10.49%. During the same quarter last year, the firm posted $0.22 earnings per share. Sell-side analysts forecast that Avantor, Inc. will post 1.06 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on AVTR. Wells Fargo & Company decreased their price target on Avantor from $28.00 to $25.00 and set an “overweight” rating for the company in a report on Monday, February 10th. Raymond James reiterated an “outperform” rating and set a $24.00 target price (down from $26.00) on shares of Avantor in a research note on Monday, February 10th. Royal Bank of Canada reduced their target price on Avantor from $33.00 to $31.00 and set an “outperform” rating for the company in a research note on Monday, February 10th. Robert W. Baird reduced their target price on Avantor from $27.00 to $26.00 and set an “outperform” rating for the company in a research note on Monday, October 28th. Finally, UBS Group reiterated a “neutral” rating and set a $25.00 target price (down from $29.00) on shares of Avantor in a research note on Friday, January 17th. Three equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $25.92.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.